Mayo Clinic Executive Summary

714 Words3 Pages

Professor Jules Angst, from the Zurich University Psychiatric Hospital, comments about the new classification defined by the DSM-5 on Bipolar disorders. He discusses the criteria to detect signs and symptoms of the condition, and reinforces the need for future investigations on this matter. Despite the author opinion about DSM-5 weaknesses, he describes the new criteria as a reliable source for an accurate diagnose. His point of view is a valuable source for understanding the new diagnostic manual for Bipolar disorder. The National Alliance on Mental Illness presents an overview of Bipolar Disorder, to support bipolar disorder patients and their families with information about symptoms, causes, diagnosis, and treatment. The overview demonstrates that the symptoms are individual characteristics rather than general. Statistics of prevalence and its severity are helpful facts to help the audience recognize the importance to learn about the condition. The Mayo Clinic offers patient help and health information about diseases and conditions. Bipolar Disorder is one of them, with a comprehensive review of symptoms, causes, risk factors, complications, psychiatrist appointment, tests, treatments, home remedies, coping, and prevention. The information provides a clear guide through the disorder not only for …show more content…

One of the objectives of the study is to compare other treatment studies and clinical experience to establish if antidepressants medication decrease depressive episodes. The study shows an update list of approved medications for Bipolar disorder. The approach for antidepressants is controversial, the study reveals the antidepressants benefits in lessening depressive symptoms, but for short-term treatment only. This article, published by Medscape, provide a comprehensive review and clinical information about the topic that help health professionals to maintain an up-to-date

Open Document